Get support Donate

SynaptixBio reaches hugely significant milestone with selection of candidate drug for clinical trials

Hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC)

https://www.synaptixbio.com/post/synaptixbio-reaches-hugely-significant-milestone-with-selection-of-candidate-drug-for-clinical-trial